Seattle Children’s is participating in a voluntary nationwide recall of several over-the-counter medications manufactured by Torrent Pharma, Inc. The manufacturer has not received any reports of harmful events related to this recall. The risk to patients is judged to be extremely low, and Seattle Children’s has found no evidence of harm to patients. It has notified all providers whose patients received the medications at Seattle Children’s.

Which medicines are included in the recall?

The recall affects medicines that were given to patients between January 2017 and May 2019 and includes:

  • Bisacodyl suppository
  • Diphenhydramine liquid
  • Guaifenesin liquid
  • Oxymetazoline nasal spray
  • Pseudoephedrine liquid

The medicines were recalled due to potential product contamination with Burkholderia cepacia and Ralstonia pickettii. Seattle Children’s has removed these medicines from all its locations. If a substitute was available, it replaced the medicines with similar products that were not affected.

What is the risk to patients?

Since most of these medicines are given orally or as a rectal suppository, they have extremely low risk of transmitting an infection.

While the risk may be higher for those with compromised immune systems or chronic respiratory illnesses, Seattle Children’s has reviewed its bacterial infection records and did not find any evidence that patients’ health was affected by this possible contamination.

Where can I get more information?

For more information about the nationwide recall, please check the FDA website www.accessdata.fda.gov/scripts/ires/index.cfm, speak with a pharmacist or call Torrent Pharma, Inc., at 800-912-9561 (8 a.m. to 5 p.m. Eastern Time).